Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
917.1 DKK | +0.78% | +3.84% | +31.37% |
04:49pm | UK weight-loss drug price rivalry intensifies with Pharmacy2U mark-down | RE |
10:05am | Novo Nordisk Owner to Buy Controlling Stake in Single Use Support | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.37% | 59TCr | |
-3.13% | 36TCr | |
+19.56% | 33TCr | |
+5.18% | 29TCr | |
+14.83% | 24TCr | |
+9.93% | 21TCr | |
-6.95% | 20TCr | |
+10.52% | 17TCr | |
+0.48% | 16TCr | |
+0.89% | 12TCr |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk, Evotec Launch Drug Discovery Accelerator for Cardiometabolic Diseases, Blood and Endocrine Disorders